Connect with us

Hi, what are you looking for?

Stock

Buy Nutrien on a retracement as price pumps ahead of quarter earnings

If you are looking for defensive stocks this year, you would hardly miss out on Nutrien Ltd (NYSE:NTR). The Canadian fertilizer manufacturer has impressive 20.13% year-to-date returns. The returns are at the current price of $82 and would be higher at over $115 price in April. 

Rising prices of farm inputs amid supply bottlenecks have been a plus for Nutrien this year. In its first quarter, the company’s earnings hit $2.49 per share, up 10 times. The company reports the second quarter earnings on August 03 after the market close. Analysts tracked by Zacks Investment Research have a consensus second-quarter earnings of $5.9. The earnings are more than double $2.08 last year.

The valuation of Nutrien looks healthy too. The forecast 12-month stock’s forward PEG ratio is $0.62. That implies that the stock is cheap, and investors could look to buy at very low prices. With the stock’s price starting to look up after the latest drop, is it time to buy?

Source – TradingView

While Nutrien appears to be under pressure after hitting $85 resistance, it remains bullish. The short-term moving averages have joined support. The MACD indicator is also bullish on the stock after bottoming at $72 in mid-July. 

Investors should take advantage of the slip in Nutrien to buy the stock. The stock can be bought where the price meets the 14-day or 21-day moving average. The second quarter results would be the catalyst for a breakout above $85, and investors should lock value.

Summary

Nutrien stock is attractive ahead of the quarterly earnings, and investors should buy the retracement. The stock is also attractively valued and could surge past the $85 resistance after the quarter results.

The post Buy Nutrien on a retracement as price pumps ahead of quarter earnings appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.






    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Stock

    Solana (SOL/USD) is enormously underrated as a cryptocurrency project, even with its hiccups – including the latest exploit on one of the ecosystem apps....

    Editor's Pick

    The new eSIM infrastructure will help modernise the IoT connectivity market with fast, secure connections and reduced vendor lock-in. 1oT, a tech startup from...

    Economy

    The latest Job Openings and Labor Turnover Survey from the Bureau of Labor Statistics shows the total number of job openings in the economy...

    Economy

    U.S. District Court Judge Reed O’Connor recently ruled to uphold the rights of employers granted in the Religious Freedom Restoration Act, rather than uphold...

    Disclaimer: Dealwithbiz.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2023 Dealwithbiz.com